Stephen J Freedland

发表

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Alan W Partin, A. Partin, P. Walsh, 2005, JAMA.

Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care

Rodolfo Montironi, Osamu Ukimura, Mark Emberton, 2013 .

Prostate-specific antigen: update 2006.

Alan W Partin, A. Partin, S. Freedland, 2006, Urology.

Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study

Daniel Moreira, Leah Gerber, G. Andriole, 2014, Clinical Cancer Research.

Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls

Kae Jack Tay, Rajan T. Gupta, J. Moul, 2016, Expert review of anticancer therapy.

Personalized prediction of tumor response and cancer progression on prostate needle biopsy.

Gerardo Fernandez, Mikhail Teverovskiy, Yevgen Vengrenyuk, 2009, The Journal of urology.

Radical prostatectomy for clinical stage T3a disease

Alan W Partin, A. Partin, P. Walsh, 2007, Cancer.

Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?

Christopher J Kane, M. Terris, S. Freedland, 2006, The Journal of urology.

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

S. Freedland, W. Aronson, Amy G. Shah, 2008, Urology.

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

Misop Han, Alan W Partin, Bruce J Trock, 2008, JAMA.

Early detection of prostate cancer: AUA Guideline.

Mohammad Hassan Murad, Michael J Barry, Peter C Albertsen, 2013, The Journal of urology.

Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database.

Christopher J Kane, M. Terris, S. Freedland, 2012, The Journal of urology.

Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.

Manisha Palta, Pretesh Patel, Joseph K Salama, 2016, International journal of radiation oncology, biology, physics.

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

Christopher J Kane, M. Terris, S. Freedland, 2003, The Journal of urology.

Examining the relationship between obesity and prostate cancer.

S. Freedland, W. Aronson, Stephen J Freedland, 2004, Reviews in urology.

The contemporary concept of significant versus insignificant prostate cancer.

Theodorus H van der Kwast, Rodolfo Montironi, Francesco Montorsi, 2011, European urology.

Obesity and prostate cancer: weighing the evidence.

S. Freedland, Stephen J Freedland, Emma H Allott, 2013, European urology.

Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.

Adam P Dicker, Elai Davicioni, Deepansh Dalela, 2017, Journal of Clinical Oncology.

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Adam P Dicker, Menggang Yu, Hussam Al-Deen Ashab, 2016, The Lancet. Oncology.